Companies & Industry »Company News»Company News Details
Company News Details

BSE   22 Oct 14 | 12:00 AM

1367.20 8.25 (0.61%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   22 Oct 14 | 12:00 AM

1369.65 9.55 (0.7%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,346.95 (1.50%)
1 Month : Rs 1,278.15 (6.97%)
1 Year : Rs 659.60 (107.28%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Hero Motocorp3,115.954.03
Tata Motors519.453.54
Maruti Suzuki3,181.703.44
Bajaj Auto2,496.103.43
Cipla626.903.43

Online Portfolio

You can create Online Portfolio here using the below button.